Zagazig University Digital Repository
Home
Thesis & Publications
All Contents
Publications
Thesis
Graduation Projects
Research Area
Research Area Reports
Search by Research Area
Universities Thesis
ACADEMIC Links
ACADEMIC RESEARCH
Zagazig University Authors
Africa Research Statistics
Google Scholar
Research Gate
Researcher ID
CrossRef
Efficacy of Prophylactic Fluconazole in Reducing Candidemia in High Risk NICU and PICU Patients
Faculty
Medicine
Year:
2012
Type of Publication:
Article
Pages:
817-824
Authors:
Mohamed, Hanan E, Latif A, Dalia Abdel, Sultan, Mohamed H
Journal:
LIFE SCIENCE JOURNAL-ACTA ZHENGZHOU UNIVERSITY OVERSEAS EDITION MARSLAND PRESS
Volume:
9
Research Area:
Life Sciences \& Biomedicine - Other Topics
ISSN
ISI:000306398400118
Keywords :
Candida colonization, candidemia, antifungal prophylaxis, Fluconazole, risk factors for candidemia, ICU infection and nosocomial infection
Abstract:
Background: Candida infection is a common cause of morbidity and mortality in neonatal intensive care unit (NICU) and pediatric intensive care unit(PICU) patients, especially those with risk factors. Objectives: To determine the prevalence of Candida species in risky NICU and PICU patients and evaluate the efficacy of prophylactic Fluconazole in reducing Candida colonization and subsequent invasive candidemia in those patients. Design: Prospective, randomized, double blind placebo controlled clinical study. Setting: Tertiary level intensive care units at pediatric department. Subjects: 80 intensive care unit high risk group patient of neonatal and pediatric age. Intervention: children were randomly grouped during first three days to receive either Fluconazole or placebo till 28 days or less, if discharged or died earlier. Weekly surveillance cultures from oropharyngeal swabs, urine, stool and sputum (when available), samples were collected from all patients and cultured on sabaroud dextrose agar media. Blood culture on Bact/ALERT (R) 3D culture system for Candida detection was done when candidemia was suspected. For positive cultures, isolates were identified by API 20c biochemical identification strips. Liver enzymes were monitored. Results: Baseline risk factors for Candida infection in Fluconazole and Placebo groups were similar. Candida colonization was reported in 35 patients (87.5\%) in the placebo group which was significantly higher (P =0.0001) than that detected among patients in the Fluconazole treated group {[} 10 patients (25\%)]. Fluconazole treated group showed significantly lower colonization with Candida albicans (C. albicans) and higher colonization with non Candida albicans (non-C. albicans) versus placebo group. Invasive Candida infection was significantly higher (P =0.03) among placebo group than Fluconazole treated one. Invasive non-C. albicans infection was reported in 9/13 patients {[}6 patients (66.6\%) in Placebo group and 3 patients (33.3\%) in Fluconazole treated group]. No significant hepatotoxicity was noticed during Fluconazole therapy. Conclusion: Prophylactic Fluconazole in risky neonatal and pediatric patients in ICU is effective in reducing Candida colonization especially C. albicans but not invasive candidemia. {[}Dalia Abdel Latif A., Mohamed H. Sultan, Hanan E. Mohamed. Efficacy of Prophylactic Fluconazole in Reducing Candidemia in High Risk NICU and PICU Patients. Life Science Journal 2012; 9(1):817-824]. (ISSN: 1097-8135). http://www.lifesciencesite.com. 118
Online
PDF
جامعة المنصورة
جامعة الاسكندرية
جامعة القاهرة
جامعة سوهاج
جامعة الفيوم
جامعة بنها
جامعة دمياط
جامعة بورسعيد
جامعة حلوان
جامعة السويس
شراقوة
جامعة المنيا
جامعة دمنهور
جامعة المنوفية
جامعة أسوان
جامعة جنوب الوادى
جامعة قناة السويس
جامعة عين شمس
جامعة أسيوط
جامعة كفر الشيخ
جامعة السادات
جامعة طنطا
جامعة بنى سويف